Debiopharm teams up with Merck KGaA and Pfizer in lung cancerSwiss biotech looks to combine small molecule drug with immunotherapy. Share XDebiopharm teams up with Merck KGaA and Pfizer in lung cancerhttps://pharmaphorum.com/news/debiopharm-teams-merck-kgaa-pfizer-lung-cancer/